| Hy-vee Pharmacy #1(1393) | |
| 410 S Riverfront Dr, Mankato, Minnesota 56001 | |
| (507) 345-5091 |
| Name | Hy-vee Pharmacy #1(1393) |
|---|---|
| Organization Name | Hy Vee Inc |
| Location | 410 S Riverfront Dr, Mankato, Minnesota 56001 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (507) 345-5091 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
Did you know that the fastest growing segment of the oral cancer community is young, healthy non-smokers? It's shocking but true. Exposure to the HPV-16 virus, the most common sexually transmitted infection, is now the leading cause of oral cancers in the U.S. There is little that can be done to stop this virus from spreading. Our only hope to save lives is through increased professional involvement and public awareness to generate early discovery of the disease process.
When NASA's space shuttle Atlantis launches for the International Space Station on Nov. 16 it will carry a University of Colorado at Boulder butterfly experiment that will be monitored by thousands of K-12 students across the nation.
› Verified 6 days ago
| NPI Number | 1316976087 |
| Organization Name | HY-VEE INC |
| Doing Business As | HY-VEE PHARMACY #1 (1393) |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 410 S Riverfront Dr, Mankato, MN 56001 |
| Phone Number | 507-345-5091 |
News Archive
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
Did you know that the fastest growing segment of the oral cancer community is young, healthy non-smokers? It's shocking but true. Exposure to the HPV-16 virus, the most common sexually transmitted infection, is now the leading cause of oral cancers in the U.S. There is little that can be done to stop this virus from spreading. Our only hope to save lives is through increased professional involvement and public awareness to generate early discovery of the disease process.
When NASA's space shuttle Atlantis launches for the International Space Station on Nov. 16 it will carry a University of Colorado at Boulder butterfly experiment that will be monitored by thousands of K-12 students across the nation.
› Verified 6 days ago
News Archive
The Bristol-Myers Squibb Foundation today announced Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office in their homes and communities and for the course of their disease.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
Did you know that the fastest growing segment of the oral cancer community is young, healthy non-smokers? It's shocking but true. Exposure to the HPV-16 virus, the most common sexually transmitted infection, is now the leading cause of oral cancers in the U.S. There is little that can be done to stop this virus from spreading. Our only hope to save lives is through increased professional involvement and public awareness to generate early discovery of the disease process.
When NASA's space shuttle Atlantis launches for the International Space Station on Nov. 16 it will carry a University of Colorado at Boulder butterfly experiment that will be monitored by thousands of K-12 students across the nation.
› Verified 6 days ago
The Ecumen Store Type: Durable Medical Equipment & Medical Supplies Supplier Location: 718 Mound Ave, Mankato, Minnesota 56001 Phone: (844) 385-8582 | |
Cvs Pharmacy #06635 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1610 Monks Ave, Mankato, Minnesota 56001 Phone: (507) 625-1553 | |
Cvs Pharmacy 03054 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1175 Madison Ave, Mankato, Minnesota 56001 Phone: (507) 625-1791 | |
Cvs Pharmacy #16190 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1850 Adams St, Mankato, Minnesota 56001 Phone: (507) 625-9009 | |
Walmart Pharmacy 10-1473 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1881 Madison Ave, Mankato, Minnesota 56001 Phone: (507) 625-1660 |